While oncogenic K-Ras and tumor-suppressive p53 modulate NADPH through malic enzyme regulation (Jiang et al., 2013a; Son et al., 2013), our study showed that silencing FOXO1 increased ROS levels and decreased NADPH levels in cancer cells. The gene discussed is TP53; the disease is cancer.